Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gruppo Oncologico Italiano di Ricerca Clinica
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent for alive patients
Patients with diagnosis of colorectal cancer with MSI-H
Patient treated with at least one administration of antibody anti PD-1 for colorectal cancer prior to 30 June 2020 outside clinical trials.
Availability of the tumor tissue from the primary tumor or a metastatic site for molecular analyses. The availability of tumor tissue is recommended but not mandatory.
You may not be if
Patients who received immunotherapy during a clinical trial.
Clareo Health | Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer
